UNLIMITED TURBO LONG - UCB | Market Closed - Euronext Paris 12:30:01 2024-06-27 pm EDT | ||
| 17 EUR | +0.83% |
|
| Current month | +12.90% | ||
| 1 month | +12.68% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
UCB
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 17 | +0.83% |
| 24-06-26 | 16.86 | +0.42% |
| 24-06-25 | 16.8 | -2.33% |
| 24-06-24 | 17.2 | -0.35% |
| 24-06-21 | 17.26 | +2.89% |
Real-time Euronext Paris
Last update June 27, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | UCB |
| Issuer | 
BNP Paribas
|
| G7ZIB | |
| ISIN | NLBNPNL22147 |
| Date issued | 2022-09-22 |
| Strike | 54.12 € |
| Maturity | Unlimited |
| Parity | 5 : 1 |
| Emission price | 3.69 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 17.33 € |
|---|---|
| Lowest since issue | 2.71 € |
Company Profile
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Sector
-
Consensus: UCB
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
137.4
EUR
Average target price
139.7
EUR
Spread / Average Target
+1.64%
- Stock Market
- Certificates
- G7ZIB Certificat
